Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · Kidney International · 2005 · 3.9K citations · Full text

Medicine, Internal Medicine, Nephrology +17

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

Chris Estes, Quentin M. Anstee, M. Arias et al. · Journal of Hepatology · 2018 · 2K citations · Full text

Medicine, Health Sciences, Epidemiologic Methods +16

Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C

Pierre Bédossa · Hepatology · 1994 · 2K citations · Full text

Medicine, Pathology, Diagnostic Pathology +16

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

Journal of Hepatology · 2015 · 1.9K citations · Full text

Medicine, Pathology, Hepatology +16